S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
Potential 500% Return From A Unique $1 Asset? (Ad)pixel
Buffett's firm buys more Apple, Amazon while betting on oil
Norway hits export record amid soaring gas prices
Stocks end higher on Wall Street; economic worries hit oil
Potential 500% Return From A Unique $1 Asset? (Ad)pixel
Myanmar executions revive pressure for more sanctions
Stocks higher on Wall Street; economic worries hit oil price
New climate deal spurs hopes of more carbon storage projects
The ONLY Way to Play Markets Like These (Ad)pixel
S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
Potential 500% Return From A Unique $1 Asset? (Ad)pixel
Buffett's firm buys more Apple, Amazon while betting on oil
Norway hits export record amid soaring gas prices
Stocks end higher on Wall Street; economic worries hit oil
Potential 500% Return From A Unique $1 Asset? (Ad)pixel
Myanmar executions revive pressure for more sanctions
Stocks higher on Wall Street; economic worries hit oil price
New climate deal spurs hopes of more carbon storage projects
The ONLY Way to Play Markets Like These (Ad)pixel
S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
Potential 500% Return From A Unique $1 Asset? (Ad)pixel
Buffett's firm buys more Apple, Amazon while betting on oil
Norway hits export record amid soaring gas prices
Stocks end higher on Wall Street; economic worries hit oil
Potential 500% Return From A Unique $1 Asset? (Ad)pixel
Myanmar executions revive pressure for more sanctions
Stocks higher on Wall Street; economic worries hit oil price
New climate deal spurs hopes of more carbon storage projects
The ONLY Way to Play Markets Like These (Ad)pixel
S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
Potential 500% Return From A Unique $1 Asset? (Ad)pixel
Buffett's firm buys more Apple, Amazon while betting on oil
Norway hits export record amid soaring gas prices
Stocks end higher on Wall Street; economic worries hit oil
Potential 500% Return From A Unique $1 Asset? (Ad)pixel
Myanmar executions revive pressure for more sanctions
Stocks higher on Wall Street; economic worries hit oil price
New climate deal spurs hopes of more carbon storage projects
The ONLY Way to Play Markets Like These (Ad)pixel
NYSEAMERICAN:INFU

InfuSystem - INFU Stock Forecast, Price & News

$8.11
+0.14 (+1.76%)
(As of 08/15/2022 12:00 AM ET)
Add
Compare
Today's Range
$7.91
$8.19
50-Day Range
N/A
52-Week Range
$6.78
$19.14
Volume
42,952 shs
Average Volume
125,884 shs
Market Capitalization
$167.84 million
P/E Ratio
15.02
Dividend Yield
N/A
Price Target
$22.00

InfuSystem MarketRank™ Forecast

Analyst Rating
N/A
0.00 Rating Score
Upside/​Downside
171.3% Upside
$22.00 Price Target
Short Interest
Healthy
0.76% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.20
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Selling Shares
$499,300 Sold Last Quarter
Proj. Earnings Growth
680.00%
From $0.05 to $0.39 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.38 out of 5 stars

INFU stock logo

About InfuSystem (NYSEAMERICAN:INFU) Stock

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

Receive INFU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InfuSystem and its competitors with MarketBeat's FREE daily newsletter.

INFU Stock News Headlines

InfuSystem Q2 2022 Earnings Preview - Seeking Alpha
See More Headlines
Receive INFU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InfuSystem and its competitors with MarketBeat's FREE daily newsletter.

INFU Company Calendar

Last Earnings
11/15/2021
Today
8/16/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSEAMERICAN:INFU
Employees
394
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$22.00
High Stock Price Forecast
$22.00
Low Stock Price Forecast
$22.00
Forecasted Upside/Downside
+171.3%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$17.33 million
Pretax Margin
0.94%

Debt

Sales & Book Value

Annual Sales
$97.39 million
Cash Flow
$0.84 per share
Book Value
$2.01 per share

Miscellaneous

Free Float
16,891,000
Market Cap
$167.84 million
Optionable
Not Optionable
Beta
1.08

Key Executives

  • Mr. Richard A. DiIorio (Age 47)
    CEO & Director
    Comp: $645.18k
  • Ms. Carrie Lachance B.S.N. (Age 45)
    M.B.A., R.N., Pres, COO & Director
    Comp: $355.54k
  • Mr. Barry G. Steele (Age 51)
    Exec. VP & CFO
    Comp: $303.33k
  • Ms. Jeannine Lombardi Sheehan (Age 48)
    Exec. VP & Chief Admin. Officer
  • Mr. Thomas Mark Ruiz (Age 64)
    Exec. VP & Chief Commercial Officer
  • Jeanie Latz
    Corp. Sec.













INFU Stock - Frequently Asked Questions

What is InfuSystem's stock price forecast for 2022?

0 Wall Street analysts have issued 1 year target prices for InfuSystem's stock. Their INFU share price forecasts range from $22.00 to $22.00. On average, they predict the company's stock price to reach $22.00 in the next year. This suggests a possible upside of 171.3% from the stock's current price.
View analysts price targets for INFU
or view top-rated stocks among Wall Street analysts.

Are investors shorting InfuSystem?

InfuSystem saw a decline in short interest during the month of July. As of July 15th, there was short interest totaling 142,300 shares, a decline of 35.3% from the June 30th total of 220,000 shares. Based on an average daily volume of 143,300 shares, the short-interest ratio is presently 1.0 days. Currently, 0.8% of the shares of the company are short sold.
View InfuSystem's Short Interest
.

How were InfuSystem's earnings last quarter?

InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU) announced its quarterly earnings results on Monday, November, 15th. The medical instruments supplier reported ($0.02) EPS for the quarter, missing analysts' consensus estimates of $0.03 by $0.05. The medical instruments supplier earned $26.57 million during the quarter, compared to analyst estimates of $28 million. InfuSystem had a net margin of 11.64% and a trailing twelve-month return on equity of 26.77%.

What guidance has InfuSystem issued on next quarter's earnings?

InfuSystem updated its FY 2022 earnings guidance on Thursday, August, 11th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $113.00 million-$116.00 million, compared to the consensus revenue estimate of $117.70 million.

What other stocks do shareholders of InfuSystem own?
What is InfuSystem's stock symbol?

InfuSystem trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "INFU."

Who are InfuSystem's major shareholders?

InfuSystem's stock is owned by many different institutional and retail investors. Top institutional investors include Meros Investment Management LP (2.51%), Russell Investments Group Ltd. (2.01%), Renaissance Technologies LLC (1.98%), Harbert Fund Advisors Inc. (1.26%), Teton Advisors Inc. (0.94%) and Millennium Management LLC (0.83%). Insiders that own company stock include Barry G Steele, Blueline Capital Partners Ii,, Carrie Lachance, Christopher R Sansone, Gregg Owen Lehman, Jeannine Sheehan, Meridian Ohc Partners, Lp, Paul Andrew Gendron, Richard Dilorio, Scott Shuda and Thomas Mark Ruiz.
View institutional ownership trends
.

How do I buy shares of InfuSystem?

Shares of INFU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is InfuSystem's stock price today?

One share of INFU stock can currently be purchased for approximately $8.11.

How much money does InfuSystem make?

InfuSystem (NYSEAMERICAN:INFU) has a market capitalization of $167.84 million and generates $97.39 million in revenue each year. The medical instruments supplier earns $17.33 million in net income (profit) each year or $0.54 on an earnings per share basis.

How many employees does InfuSystem have?

The company employs 394 workers across the globe.

How can I contact InfuSystem?

InfuSystem's mailing address is 31700 Research Park Dr, MADISON HEIGHTS, MI 48071-4627, United States. The official website for the company is ir.infusystem.com. The medical instruments supplier can be reached via phone at (124) 291-1210 or via fax at 800-455-4338.

This page (NYSEAMERICAN:INFU) was last updated on 8/16/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.